A meta-analysis including a total of 19 publications with ~1,100 paired primary and secondary CRC tissues has recently confirmed an extremely high concordance of the KRAS genotype in primary and metastatic tumors, while also showing the highest rates of discrepancies in lymph node metastases as compared with correspondent primary CRC (41). This evidence concerns the gene KRAS and metastatic neoplasm.